How to overcome multidrug resistance in chemotherapy for advanced hepatocellular carcinoma

Liver Int. 2010 Apr;30(4):496-8. doi: 10.1111/j.1478-3231.2010.02215.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / pathology
  • Drug Resistance, Multiple / genetics*
  • Drug Resistance, Neoplasm
  • Drug Screening Assays, Antitumor
  • Female
  • Genes, MDR / genetics*
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / mortality
  • Liver Neoplasms / pathology
  • Male
  • Neoplasm Staging
  • Prognosis
  • Risk Assessment
  • Survival Analysis
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / administration & dosage

Substances

  • Tumor Necrosis Factor-alpha